12 August 2023 : Clinical Research
Transgastric Jejunostomy (PEG-J) for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel: An Approach for Parkinson's Disease Treatment
Yusuke Nomoto1ABCDEF*, Makoto Furihata1ABCDEF, Haruka Hagiwara1F, Hirotaka Ishino1B, Shintaro Yano1D, Hiroki Okawa1B, Yoichi Nakatsu1B, Kumiko Noda1B, Shinjiro Nishi1F, Shingo Ogiwara1AB, Tsuneo Kitamura1D, Taro Osada1AGDOI: 10.12659/MSM.941285
Med Sci Monit 2023; 29:e941285
Table 3 Device-related adverse events.
Device-related AEs | Patients | Rate (%)*1 | Frequency | Rate (%)*2 |
---|---|---|---|---|
Inflection (catheter) | 12 | 27.9 | 28 | 63.6 |
Inadvertent removal (catheter) | 8 | 18.6 | 9 | 20.5 |
Breakage (particle) | 6 | 14.0 | 7 | 15.9 |
Migration (catheter) | 0 | 0.0 | 0 | 0.0 |
Occlusion (catheter) | 0 | 0.0 | 0 | 0.0 |
Total | 26 (22)*3 | 60.5 (51.2)% | 44 | 100.0 |
AE – adverse events. *1 The rate was calculated as total patients divided by all enrolled patients (n=43); *2 Rate was calculated as frequency divided by total frequency; *3 A total of 26 patients. Four patients experienced 2 AEs in duplicate. |